Site search
2897 results for '' found
Evaluating a telehealth exercise model of care for adults with CF: A feasibility randomised controlled trial (ACTRN12625000116426)
Evaluating a telehealth exercise model of care for adults with CF: A feasibility randomised controlled trial (ACTRN12625000116426)
/
Imaging Astrogliosis in Patients with Epilepsy with [18F]-FDED PET (ACTRN12625000170426)
Imaging Astrogliosis in Patients with Epilepsy with [18F]-FDED PET (ACTRN12625000170426)
/
An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participa
An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participa
/
Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke (NCT05203224)
Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke (NCT05203224)
/
Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke (NCT05892510)
Post-thrombectomy intra-arterial tenecteplase for Acute manaGement of Non-retrievable thrombus and no-reflow in Emergent Stroke (NCT05892510)
/
Safety and Effectiveness of an Expandable/Retractable Introducer Sheath (ACTRN12623000479606p)
Safety and Effectiveness of an Expandable/Retractable Introducer Sheath (ACTRN12623000479606p)
/
Evolut™ EXPAND TAVR II Pivotal Trial (NCT05149755)
Evolut™ EXPAND TAVR II Pivotal Trial (NCT05149755)
/
Exercise as an immunomodulatory intervention and adjuvant to vaccination in people with COPD: feasibility randomised controlled trial. (ACTRN12624000372583)
Exercise as an immunomodulatory intervention and adjuvant to vaccination in people with COPD: feasibility randomised controlled trial. (ACTRN12624000372583)
/
A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Iberdomide, Daratumumab and Dexametasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects wit
A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Iberdomide, Daratumumab and Dexametasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects wit
/
A Phase 2 Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The EvolvE Study) (NCT05
A Phase 2 Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The EvolvE Study) (NCT05
/